 LONDON and NEW YORK, April 19, 2021 GLOBE NEWSWIRE -- MeiraGTx Holdings plc Nasdaq: MGTX, a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., president and chief executive officer, and Stuart Naylor, Ph.D., chief development officer, will participate in a fireside chat at the Chardan Virtual Genetic Medicines Manufacturing Summit on Monday, April 26, 2021 at 1:45 p.m. ET. 